Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Further Restricts Antibiotic Use, Expands Monitoring Networks To More Hospitals

This article was originally published in PharmAsia News

Executive Summary

As the world’s largest consumer of antibiotics, China will soon implement a new regulation that further restricts use, and expands monitoring of adverse events and drug resistance.


Related Content

Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?
China To Issue Strict Limits On Antibiotic Usage By July; Large Sales Cuts Expected
Big Pharma Takes Another Haircut As China Slashes Drug Prices In Two Largest Therapy Fields


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts